# Actimus BioSciences Private Ltd. – FDA Inspection, Feb 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/actimus-biosciences-private-ltd/d73bfa03-cff9-4d15-a1cc-bfb6495a964b
Source feed: FDA_Inspections

> FDA inspection 1087025 of Actimus BioSciences Private Ltd., February 22, 2019. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087025
- Company Name: Actimus BioSciences Private Ltd.
- Inspection Date: 2019-02-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1232136 - 2024-02-02
- FDA Inspection 1219736 - 2023-09-22
- FDA Inspection 1177347 - 2022-07-14

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/sripal-r-mada/38ce7c12-1405-436b-ac3e-55149c953537)

Company: https://www.keypedia.com/companies/actimus-biosciences-private-ltd/f668409f-a167-4e1a-ac4f-9566691bf987

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c